New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 16, 2014
11:16 EDTSVU, QEP, NAO, SD, KKR, C, GLPI, ACTCooperman lists Actavis, Citigroup, KKR among top-picks, CNBC says
Leon Cooperman of Omega Advisors listed Actavis (ACT), Citigroup (C), KKR (KKR), Gaming and Leisure Properties (GLPI), Nordic American Offshore (NAO) and SuperValu (SVU), QEP Resources (QEP) and SandRidge Energy (SD) among his top stock picks while presenting at the "Delivering Alpha" conference, according to CNBC.
News For ACT;C;KKR;GLPI;NAO;SVU;SD;QEP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 23, 2015
10:02 EDTQEPOn the Fly: Analyst Initiation Summary
Subscribe for More Information
07:23 EDTCBass does not expect large U.S. banks to break up
Publicly traded companies in the space include Bank of America (BAC), Citi (C), JPMorgan (JPM), and Wells Fargo (WFC). Kyle Bass of Hayman Capital continues speaking on CNBC.
07:12 EDTQEPQEP Resources reinstated with a Hold at Deutsche Bank
Subscribe for More Information
07:08 EDTCNorwegian Statoil seeks to cut costs as oil prices drop, WSJ says
Subscribe for More Information
06:42 EDTCU.S. banks preparing for prolonged low bond yields, Reuters says
Subscribe for More Information
January 22, 2015
15:26 EDTCCiti to hold a conference call
4Q14 Fixed Income Investor Review conference call to be held on January 23 at 11 am. Webcast Link
09:43 EDTSDActive equity options trading
Active equity options trading according to Track Data: AAPL DG ABX AMZN FXCM LVS FFIV INFI SD
07:26 EDTKKRKKR issues some refunds after SEC findings, WSJ says
Subscribe for More Information
05:57 EDTACTActavis, Valeant raise prospects of more healthcare deals, Financial Times says
Subscribe for More Information
05:36 EDTKKRKKR acquires Trainline, details not disclosed
Subscribe for More Information
January 21, 2015
16:00 EDTCOptions Update; January 21, 2015
iPath S&P 500 VIX Short-Term Futures down 1.63 to 33.49. Option volume leaders: AAPL TSLA TWTR AMZN FB RIG C ABX SIRI NFLX according to Track Data.
12:30 EDTACTGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information
07:22 EDTACTActavis price target raised to $330 from $280 at Deutsche Bank
Subscribe for More Information
January 20, 2015
16:00 EDTCOptions Update; January 20, 2015
iPath S&P 500 VIX Short-Term Futures down 36c to 35.12 Option volume leaders: AAPL TSLA TWTR GILD NFLX MGM ABX AMAT JNJ C according to Track Data.
11:52 EDTKKRKKR seeks $3B for distressed fund targeting oil companies, Asia, Bloomberg says
Subscribe for More Information
09:38 EDTCActive equity options trading
Subscribe for More Information
07:31 EDTSDSandRidge Energy upgraded to Hold from Reduce at KLR Group
Subscribe for More Information
05:34 EDTACTActavis reports positive Phase III results for cariprazine
Gedeon Richter and Actavis announced positive results from a Phase III trial evaluating the efficacy and safety of cariprazine in the prevention of relapse in patients with schizophrenia. There were 101 patients randomized to cariprazine 3 to 9 mg per day and 99 randomized to placebo. The primary efficacy measure was time to first relapse during the double-blind period. There were 25 relapses in the cariprazine group versus 47 relapses in the placebo group. Treatment with cariprazine was associated with a 55% reduction in risk of relapse versus placebo.
January 18, 2015
16:57 EDTCCiti may have lost more than $150M on Swiss franc volatility, Bloomberg says
Subscribe for More Information
15:14 EDTCMashreqbank interested in Citigroupís Egyptian consumer unit, Bloomberg says
Dubai-based bank, Mashreqbank PSC confirmed it is interested in acquiring Citigroupís Egyptian consumer banking unit, says Bloomberg citing comments from Mashreqbank PSC CEO Abdul Aziz Al Ghurair. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use